Crizac Limited IPO to Open on July 2, 2025: Check Latest GMP, Issue Details
Crizac Limited, a B2B educational platform, is launching its IPO on July 2, 2025. The bidding window will remain open till July 4, 2025, for public subscription. The allotment process is expected to be finalised on Monday, July 7, 2025. The shares will be listed on BSE and NSE with a tentative listing date fixed as Wednesday, July 9, 2025.
Issue Details
Crizac IPO is a bookbuilding of ₹860 crores. The issue is entirely an offer for sale of 3.51 crore shares. The IPO price band is set at ₹233 to ₹245 per share. The minimum lot size for an application is 61, and the minimum amount of investment required is ₹14,213.
Equirus Capital Private Limited and Anand Rathi Advisors Limited will be the book-running lead managers for the Crizac Limited IPO. MUFG Intime India Private Limited (formerly Link Intime India Private Limited) will be the registrar for the issue.
GMP Details
Ahead of its IPO, the Grey Market Premium (GMP) of Crizac Limited stood at ₹0 as of July 1, 2025, 11:19 a.m. This indicates a flat listing of the shares at ₹245, with no premium or discount.
|
Source: Livemint Media Report dated July 1, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
About Crizac Limited
Founded in 2011, Crizac Limited is a B2B education platform agents and global institutions. It provides recruitment solutions to global institutions of higher education in the United Kingdom, Canada, the Republic of Ireland, Australia and New Zealand (ANZ).
As of September, 2024, the company have around 7,900 agents globally and have also processed over 5.95 lakh student applications.
|
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory. To read the RA disclaimer, please click here |